Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | A-1210477 |
Trade Name | |
Synonyms | AOB5551 |
Drug Descriptions |
A-1210477 binds to and inhibits MCL1, resulting in increased apoptosis of MCL1-dependent tumor cells (PMID: 25590800, PMID: 30647404, PMID: 32486166). |
DrugClasses | MCL1 Inhibitor 18 |
CAS Registry Number | 1668553-26-1 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
A-1210477 | A-1210477 | 1 | 0 |
A-1210477 + A-1331852 | A-1210477 A-1331852 | 0 | 0 |
A-1210477 + Cobimetinib | A-1210477 Cobimetinib | 0 | 0 |
A-1210477 + Cobimetinib + Vemurafenib | A-1210477 Cobimetinib Vemurafenib | 0 | 0 |
A-1210477 + G-TPP | A-1210477 G-TPP | 0 | 0 |
A-1210477 + LAM-003 | A-1210477 LAM-003 | 0 | 0 |
A-1210477 + Lapatinib + WEHI-539 | A-1210477 Lapatinib WEHI-539 | 0 | 0 |
A-1210477 + Vemurafenib | A-1210477 Vemurafenib | 0 | 0 |
A-1210477 + Venetoclax | A-1210477 Venetoclax | 1 | 0 |
A-1210477 + WEHI-539 | A-1210477 WEHI-539 | 1 | 0 |